ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 56 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34,303 | +121.6% | 21,574 | 0.0% | 0.00% | – |
| Q1 2023 | $15,477 | -88.2% | 21,574 | +61.0% | 0.00% | -100.0% |
| Q1 2020 | $131,000 | -88.4% | 13,396 | -86.4% | 0.00% | -87.5% |
| Q4 2019 | $1,133,000 | +180.4% | 98,373 | +32.7% | 0.01% | +166.7% |
| Q3 2019 | $404,000 | +45.3% | 74,127 | +216.9% | 0.00% | 0.0% |
| Q2 2019 | $278,000 | +13800.0% | 23,391 | +3642.6% | 0.00% | – |
| Q4 2018 | $2,000 | -98.1% | 625 | -96.5% | 0.00% | -100.0% |
| Q1 2018 | $104,000 | +116.7% | 18,008 | +30.7% | 0.00% | – |
| Q4 2017 | $48,000 | +128.6% | 13,776 | +134.4% | 0.00% | – |
| Q3 2017 | $21,000 | +23.5% | 5,876 | -14.8% | 0.00% | – |
| Q2 2017 | $17,000 | -10.5% | 6,895 | 0.0% | 0.00% | – |
| Q1 2017 | $19,000 | +26.7% | 6,895 | +30.1% | 0.00% | – |
| Q4 2016 | $15,000 | +66.7% | 5,298 | +141.0% | 0.00% | – |
| Q3 2016 | $9,000 | -79.5% | 2,198 | -84.3% | 0.00% | -100.0% |
| Q2 2016 | $44,000 | – | 13,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |